Patents by Inventor Yongming Bao

Yongming Bao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240179145
    Abstract: A method for connection establishment and an Internet of Things (IoT) device are disclosed. The method is performed by a configuration device, including: acquiring token information of a service device from a cloud device; and sending the token information to the service device, the token information being configured for establishing a certificate authenticated session establishment (CASE) connection between the service device and the cloud device.
    Type: Application
    Filed: February 1, 2024
    Publication date: May 30, 2024
    Applicant: GUANGDONG OPPO MOBILE TELECOMMUNICATIONS CORP., LTD.
    Inventor: Yongming Bao
  • Publication number: 20230208716
    Abstract: Provided are a control method, comprising: when establishing a first binding relationship with a first account number, a CHIP device meeting an original binding relationship release condition, releasing the first binding relationship, and establishing a second binding relationship with a second account number, such that a second configuration device using the second account configures the CHIP device. Further provided are another control method, a device, and a storage medium.
    Type: Application
    Filed: December 23, 2022
    Publication date: June 29, 2023
    Inventors: Yongming BAO, Zhao RU, Xiaoqiang LYU
  • Patent number: 8377895
    Abstract: The present invention provides a series of cyclin-dependent protein kinases (Cdks) inhibitors, Scutellaria flavonoid organic amine derivatives, synthesis and use thereof. The preparation method is as follows: taking Baicalein (or Wogonin) from Scutellaria baicalensis as lead compound, mixting it with formaldehyde solution and organic amine compounds based on the molar ratio of 1:1-1.2:1-1.2, adding methanol of duplicate weight than baicalein and reacting at 50-70° C., filtering the sediment and washing and then drying so as to get the product with a content of not less than 97% (weight). Similar to Flavopiridol and P276-00, the activity of baicalein organic amine derivatives inhibiting Cdks has an increase of 50 times compared with that of Baicalin. It can selectively induce apoptosis of the proliferative phase cancer cells, which has scarcely any influence to the normal structure, and it belongs to anticancer drugs of cell cycle inhibitor kind.
    Type: Grant
    Filed: July 7, 2009
    Date of Patent: February 19, 2013
    Inventors: Shixuan Zhang, Yongming Bao, Yuming Sun, Kangjian Li, Liang Zou, Jigang Ma, Xiaodan Sun, Haiyan Shang, Jing Li
  • Publication number: 20100197619
    Abstract: The present invention provides a series of cyclin-dependent protein kinases (Cdks) inhibitors, Scutellaria flavonoid organic amine derivatives, synthesis and use thereof. The preparation method is as follows: taking Baicalein (or Wogonin) from Scutellaria baicalensis as lead compound, mixting it with formaldehyde solution and organic amine compounds based on the molar ratio of 1:1-1.2:1-1.2, adding methanol of duplicate weight than baicalein and reacting at 50-70° C., filtering the sediment and washing and then drying so as to get the product with a content of not less than 97% (weight). Similar to Flavopiridol and P276-00, the activity of baicalein organic amine derivatives inhibiting Cdks has an increase of 50 times compared with that of Baicalin. It can selectively induce apoptosis of the proliferative phase cancer cells, which has scarcely any influence to the normal structure, and it belongs to anticancer drugs of cell cycle inhibitor kind.
    Type: Application
    Filed: July 7, 2009
    Publication date: August 5, 2010
    Inventors: Shixuan Zhang, Yongming Bao, Yuming Sun, Kangjian Li, Liang Zou, Jigang Ma, Xiaodan Sun, Haiyan Shang, Jing Li